protocols
[대역어] 프로토콜
[용어속성] Term
[용어속성] Term
SARS-CoV-2 Seroprevalence among Health Care Workers—A Voluntary Screening Study in a Regional Medical Center in Southern Germany
의료 종사자 사이의 SARS-CoV-2 혈청 유병률 - 독일 남부 지역 의료 센터의 자발적 선별 연구
Article
Published on
Journal: International Journal of Environmental Research an [Category] MERS, SARS, 진단, 치료기술,
Journal: International Journal of Environmental Research an [Category] MERS, SARS, 진단, 치료기술,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Care
center
clinical manifestation
close contact
collected
confirmation
Contact
contact with
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
COVID-19
early phase
effective
ELISA
followed by
Germany
HCW
HCWs
Health
Health care
health care personnel
Health care system
health care workers
house
hygiene
IgA
information
Neutralization assay
Neutralizing
no significant difference
pandemic
pathogen
Patient
Personal protective equipment
preventive measure
preventive measures
PROTECT
protocols
Regional
respiratory
risk
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2-specific antibodies
SARS-CoV-2-specific antibody
Screening
Seroprevalence
serum sample
serum samples
Seven
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
specific antibodies
technique
tested
Transmission
virus
voluntary
were used
[DOI] 10.3390/ijerph18083910 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijerph18083910 PMC 바로가기 [Article Type] Article
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
Review
[키워드] administration
adverse events
antibodies
antibody
Antibody titers
Antiviral
antiviral activity
articles
benefit
Case report
Case series
Case-control
caused
Clinical studies
clinical study
conducted
convalescent plasma
COVID-19
COVID-19 infection
COVID-19 pandemic
CP antibody
criteria
Critically ill
data extraction
demographics
directive
Donor
dose
effective
Efficacy
eligible
Evidence
Future
generate
Guidance
heterogeneity
identify
immunology
Immunotherapy
in vitro
incidence
independent
item
knowledge
literature
mechanically ventilated
Meta-analysis
MOST
nonrandomized
Novel coronavirus
objective
offer
Patient
patients with COVID-19
performed
plasma
poor quality
prevention
Prophylactic
protocols
Quality
Quantitative
Quantitative analysis
random-effects model
Randomized controlled trial
RCT
RCTs
recommendation
reduce mortality
reported
Reporting
Research
Result
review
robust
SARS-CoV-2
screening process
searched
Spread
Support
supportive care
systematic review
therapeutic
Therapeutic treatment
therapy
therapy for COVID-19
Treatment
viral clearance
virus
Web of Science
[DOI] 10.2196/25500 PMC 바로가기 [Article Type] Review
[DOI] 10.2196/25500 PMC 바로가기 [Article Type] Review
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
중증 코로나19 환자 치료에 이버멕틴 추가의 유효성 및 안전성 평가
Clinical Trial
[키워드] added
affecting
Alter
average
Azithromycin
azithromycin-
blood lymphocyte count
C-reactive protein
can be used
cause
changes in
Clinical improvement
clinical recovery
clinical response
control group
control groups
COVID-19
COVID-19 disease
COVID-19 pandemic
COVID-19 pneumonia
COVID19 pneumonia
CRP
D-dimer level
D-dimer levels
decrease
drug
Effect
effective
Effectiveness
enteral use
evaluate
evaluated
Favipiravir
ferritin
FiO2
follow-up period
gene mutation
gene mutations
genetic test
genetic tests
groups
Hydroxychloroquine
increase in
investigated
Ivermectin
ivermectin metabolism
ivermectin treatment
laboratory parameter
Laboratory parameters
lymphocyte
material
metabolism
Mortality
mortality rate
mortality rates
Mutation
oxygen
oxygen saturation
PaO2
partial pressure
Partial pressure of oxygen
Patient
patients
performing sequence analysis
peripheral capillary
phase 3 study
Pneumonia
prognostic
protocol
protocols
randomization
Randomized
reduction in
reference treatment
Result
Sanger method
SARS CoV-2
SARS-CoV2
Sequence analysis
serum
serum C-reactive protein
severe COVID-19
severe COVID-19 patient
Severe COVID-19 pneumonia
single-blind
solution
SpO2
study group
supplementary material
the study group
toxic effect
toxic effects
Treatment
two groups
were excluded
were given
while
PMC 바로가기 [Article Type] Clinical Trial
PMC 바로가기 [Article Type] Clinical Trial
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study
입원하지 않은 경증에서 중등도의 COVID-19 환자에서 장내 미생물군유전체 조절의 자연사 및 영향을 평가하기 위한 가상화된 임상 연구 장내 미생물군 구조에 대한 KB109의 생리학적 효과를 평가하는 병렬 그룹 연구와 함께 무작위, 공개, 전향적 연구 및 기능: 무작위 대조 연구를 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
24 hours
Ability
absence
addition
adhere
Affect
age
Ageusia
allergy
analysed
Anosmia
Anosmia/ageusia
Antacid
Antibiotics
Antiviral
assessment
assigned
Autoimmune disease
Bariatric surgery
baseline
bilevel positive airway pressure
Biomarker
Biomarkers
biomarkers of inflammation
BiPAP
Blinding
blocker
Blood
blood sample
Blood samples
both groups
bowel
bowel resection
breath
Care
care provider
Cell
change
Chest
chest tightness
chills
chronic lung disease
cirrhosis
clinical
clinical study
clinical trial
Cold
collected
Community
Comorbidity
comparator Patients
completion
Compliance
component
computer
Concomitant medication
concomitant medications
concurrent
condition
conducted
contraindications
coronavirus disease
Coronavirus disease 2019
cough
COVID-19
COVID-19 in patient
COVID-19 symptom
COVID-19 symptoms
COVID-19 testing
COVID-19-related symptom
COVID-19-related symptoms
COVID-19–related symptom
COVID-19–related symptoms
CPAP
Cytokines
D-dimer
daily dose
Day
defined
diarrhea
dissemination
drug
duration of symptom
Effect
element
eligible
Enrollment
evaluate
evaluate the effect
evaluated
exacerbated
exclusion criteria
exploratory
fatigue
fatty
Fatty acid
feasible
Female patients
Fever
fiber
Follow-up
follow-up period
following
group
Gut
gut microbiome
gut microbiome composition
gut microbiota
headache
Health
Health care
Health Care Utilization
Health status
healthcare
Histamine
history
hospital
Hospital admission
Hospital admissions
Hospitalization
Hospitalized
hypoxia
Identifier
IgM/IgG
Immunity
immunomodulatory
immunosuppressive
immunosuppressive therapy
in both group
include
Infection
Inflammation
Inflammatory biomarker
Inflammatory bowel disease
information
Informed consent
inhibitors
intake
Interaction
investigational agent
irritable bowel syndrome
KB109
Laboratory
laboratory measures
lactating
library
life
Liver disease
Lung disease
magnitude
malignancy
management
measure
Measures
medication
medications
Medicine
metabolite
Microbiome
microbiota
Mild
mild to moderate
Mild to moderate COVID-19
mild to moderate disease
moderate
Moderate COVID-19
moderate disease
modulate
modulation
muscle pain
nasal congestion
neutralization assays
not limited
nucleic acid
number
objective
Open-label
opinion
other compound
other compounds
outcome
outcome measure
Outpatient
outpatients
oxygen
oxygen saturation
Oxygen therapy
Pain
parallel group
participant
Participation
Patient
patient population
Period
Physical examination
positive airway pressure
Positive test
Potential
pre-symptomatic
pregnant
Primary outcome
progression
proportion
proportions
Prospective Study
PROTECT
protocol
protocols
proton pump
provided
pulse
Pulse oximeter
Quality of life
Quantitative
question
randomisation
randomised
randomised controlled study
randomization
Randomized
randomized controlled study
receive
recruitment
reduction
Registered
reported
response
resting position
risk
risk of infection
Sample size
screened
selected
self-care
sensitivities
Sequencing
serological
serology
shaking
short-chain fatty acids
Shortness of breath
Sleep
sleep apnea
Smartphone
sore throat
specific biomarker
specific biomarkers
Spread
SSC
Standard
Stool
stratified
Study design
Study protocol
study visit
supplementary material
Swab
Symptom
symptomatic patient
Symptomatic patients
Symptoms
syndrome
Tablet
TEAEs
Telemedicine
telephone
temperature
the patient
The United States
therapy
time
Tolerability
Treatment
treatment-emergent adverse event
undergo
United States
unlikely
Viral
Viral load
water
website
worsening
[DOI] 10.1186/s13063-021-05157-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05157-0 PMC 바로가기 [Article Type] Letter
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak
Observational Study
[키워드] activities
activity
affected
allocation
Allocation resources
cancer patient
Care
COVID-19
COVID-19 infection
COVID-19 patients
death
described
Gynaecological cancers
healthcare
high risk
Italian
Italian region
Italy
lack
lockdown
majority
material
Measures
oncology
outbreak
outcome
outcomes
ovarian cancer
pandemic
pathway
Patient
performed
prospective observational study
protocols
resource
SARS-CoV-2
surgical
the SARS-CoV-2
unit
university
were recorded
[DOI] 10.1016/j.ygyno.2020.09.030 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.ygyno.2020.09.030 PMC 바로가기 [Article Type] Observational Study
Stochastic sampling effects favor manual over digital contact tracing
확률적 샘플링 효과는 디지털 접촉 추적보다 수동을 선호합니다.
Article
[키워드] Combination
complementary
Complex networks
Contact
Contact tracing
Contagion
COVID-19 pandemic
decision
determined by
diffusion
dominant
Effect
Effectiveness
Epidemiology
explained
favor
heterogeneity
infected individual
Infection
intrinsic
intrinsically
Isolation
manual
parameter
Probability
protocol
protocols
provided
SARS-CoV-2
stochastic
super-spreaders
symptomatic individuals
tracing
[DOI] 10.1038/s41467-021-22082-7 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-021-22082-7 PMC 바로가기 [Article Type] Article
Dentists’ Working Conditions during the First COVID-19 Pandemic Lockdown: An Online Survey
Article
[키워드] Analysis
asked
condition
conditions
consequence
coronavirus disease
country
COVID-19
dentist
dentistry
Europe
Germany
heterogeneous
high risk
indicated
Infection
Italy
lack
lockdown
management
MOST
online survey
Pain
participant
Participants
performed
Personal protective equipment
protocols
provided
quantified
question
questionnaire
reduced
Respirator
SARS-CoV-2
South
Support
survey
Switzerland
Treatment
working
[DOI] 10.3390/healthcare9030364 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/healthcare9030364 PMC 바로가기 [Article Type] Article
COVID-19 Pandemic on Fire: Evolved Propensities for Nocturnal Activities as a Liability Against Epidemiological Control
Psychology
[키워드] activities
activity
adaptive
Against
age
amplify
Asymptomatic individuals
avoidance
chronotype (morningness–eveningness)
conditions
Contagion
contagious
Control
COVID-19
COVID-19 pandemic
creating
disease
disrupt
environmental condition
epidemiological
evade
evolutionary mismatch hypothesis
evolutionary psychology
Factor
favor
health measures
Human
Hypothesis
identity
immune system
individual
life history
life history theory
measure
mechanisms
Mild
Night-time
nocturnal
Non-adherence
non-compliance behavior
occur
pandemic
pandemic (COVID-19)
Pandemics
paranoid
presymptomatic
protocol
protocols
Psychological
Research
SARS-CoV-2 virus
secure
Sex
shown
social contact
social distancing
superspreading event
survival
the SARS-CoV-2 virus
traits
Variation
[DOI] 10.3389/fpsyg.2021.646711 PMC 바로가기 [Article Type] Psychology
[DOI] 10.3389/fpsyg.2021.646711 PMC 바로가기 [Article Type] Psychology
T Cells Plead for Rejuvenation and Amplification; With the Brain’s Neurotransmitters and Neuropeptides We Can Make It Happen
회춘과 증폭을 위한 T 세포 주장; 뇌의 신경전달물질과 신경펩티드로 우리는 그것을 실현할 수 있습니다
Review
[키워드] activate
activated
acute SARS-CoV-2 infection
Adoptive Cell Therapy
aging
binding
Brain
Can
Cancer
Cell
cell surface
chemotactic
chronic infections
clinical trials
CNS
cytokine
cytokine secretion
damage
decrease
Depression
diagnostic
Dopamine
Effect
Effects
Efficacy
Ex vivo
expressed
extravasation
Gene Expression
Glutamate
GnRH
high risk
Immunotherapy
IMPROVE
induce
Infection
infections
Inflammation
Injury
integrin
integrin-mediated
killing
limit
microorganism
microorganisms
Migration
Mortality
natural
Nerve-Driven Immunity
nervous
Neuropeptide
Neuropeptide Y
Neuropeptides
neurotransmitter
Neurotransmitters
organization
organizations
other diseases
other treatments
overcome
PD-1
proliferation
protocols
receptor
Rejuvenation
repeated
SARS-COV-2 infection
senescent
Somatostatin
Stress
suggested
System
T cell
T cells
tested
the cell
therapeutic
tissue repair
trauma
[DOI] 10.3389/fimmu.2021.617658 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fimmu.2021.617658 PMC 바로가기 [Article Type] Review